Hangzhou, Zhejiang, China Holley Group is the famous Corporate Investor, which was founded in 1970. The venture was found in Asia in China. The main department of described Corporate Investor is located in the Hangzhou.
The usual cause for the fund is to invest in rounds with 1 partaker.
We can highlight the next thriving fund investment areas, such as Information Technology, Blockchain. Besides, a startup requires to be at the age of 1 and less years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Everex. For fund there is no match between the country of its foundation and the country of its the most frequent investments - Singapore.
The top activity for fund was in 2017. The fund is constantly included in less than 2 investment rounds annually. Deals in the range of 100 thousands - 1 million dollars are the general things for fund.
Related Funds
| Fund Name | Location |
| Africa Agriculture and Trade Investment Fund | - |
| Behrman Capital | New York, New York, United States |
| Eminent Venture Capital | - |
| Fabick CAT | Fenton, Missouri, United States |
| Galera Angels | Missouri, St Louis, United States |
| Henderson Global Investors | England, London, United Kingdom |
| Interpublic Group | New York, New York, United States |
| Jia Zhong Guang Li Touzi | Beijing, Beijing, China |
| Kickstarter | Brooklyn, New York, United States |
| Konsortium | Bayern, Germany, Gersthofen |
| LSL Property Services | Australia, New South Wales, Newcastle |
| NetMile | Japan, Tokyo |
| Qmangel Investment Partnership | Beijing, Beijing, China |
| Red Light Management | Charlottesville, United States, Virginia |
| Shenzhenshi Yunhang Keji Youxian Gongsi | China, Guangdong, Shenzhen |
| The Cleveland Foundation | Cleveland, Ohio, United States |
| The Seed Capital | Japan, Tokyo |
| Xiaofu Capital | Beijing, Beijing, China |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Chuangjian Medical | $30M | 10 Aug 2022 | Changzhou, Zhejiang, China | ||
| $3M | 16 Aug 2017 | China, Zhejiang | |||
Everex | $500K | 24 Jul 2017 | Singapore, Central, Singapore | ||
HOUDAR | $4M | 14 Dec 2015 | Shangcheng District, Zhejiang, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Chuangjian Medical | $30M | 10 Aug 2022 | Changzhou, Zhejiang, China | ||
| $3M | 16 Aug 2017 | China, Zhejiang | |||
Everex | $500K | 24 Jul 2017 | Singapore, Central, Singapore | ||
HOUDAR | $4M | 14 Dec 2015 | Shangcheng District, Zhejiang, China |
